InsiderTrades

Form 4 for BLFS BIOLIFE SOLUTIONS INC

Accepted 2022-02-14 00:00:00 ET · period of report 2022-02-10 · accession 0001437749-22-003347 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2022-02-14 2022-02-10 BLFS Schulz Marcus Chief Revenue Off S - Sale $29.38 -167 28.2K -0.6% -$4,906

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-02-10 S D 167 $29.38 28,224 D — —